Combinatorial expression of microtubule-associated EB1 and ATIP3 biomarkers improves breast cancer prognosis
Authors:
- 27 October 2018
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 173 (3) , 573-583
Abstract
The identification of molecular biomarkers for classification of breast cancer is needed to better stratify the patients and guide therapeutic decisions. The aim of this study was to investigate the value of MAPRE1 gene encoding microtubule-end binding proteins EB1 as a biomarker in breast cancer and evaluate whether combinatorial expression of MAPRE1 and MTUS1 gene encoding EB1-negative regulator ATIP3 may improve breast cancer diagnosis and prognosis.Keywords
Funding Information
- Agence Nationale de la Recherche (ANR-11-IDEX-0001-02)
- Fondation ARC pour la Recherche sur le Cancer
- Ligue Contre le Cancer
- Odyssea Association FR
- Association PROLIFIC
- Association GEFLUC
- LabEx LERMIT
This publication has 30 references indexed in Scilit:
- TTK/hMPS1 Is an Attractive Therapeutic Target for Triple-Negative Breast CancerPLOS ONE, 2013
- Polo-like Kinase 1: A Potential Therapeutic Option in Combination with Conventional Chemotherapy for the Management of Patients with Triple-Negative Breast CancerCancer Research, 2013
- Proteomic-based identification of the APC-binding protein EB1 as a candidate of novel tissue biomarker and therapeutic target for colorectal cancerJournal of Proteomics, 2012
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast CancerJournal of Oncology Practice, 2010
- An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patientsBreast Cancer Research and Treatment, 2009
- 8p22 MTUS1 Gene Product ATIP3 Is a Novel Anti-Mitotic Protein Underexpressed in Invasive Breast Carcinoma of Poor PrognosisPLOS ONE, 2009
- Exonic expression profiling of breast cancer and benign lesions: a retrospective analysisThe Lancet Oncology, 2009
- Proteomic profiling reveals the prognostic value of adenomatous polyposis coli–end-binding protein 1 in hepatocellular carcinomaHepatology, 2008
- Dynamics and mechanics of the microtubule plus endNature, 2003
- Characterization of Human MAPRE Genes and Their ProteinsGenomics, 2001